THE MMP9 −1562 C/T POLYMORPHISM IS ASSOCIATED WITH INCREASED RISK OF DIABETIC RETINOPATHY IN TURKISH TYPE 2 DIABETES MELLITUS PATIENTS

Abstract

Objective Type 2 diabetes mellitus (T2DM) and diabetic retinopathy (DR) development is affected by genetic factors. Matrix metalloproteinases (MMPs) are involved in many cellular processes, such as remodeling of extracellular matrix proteins and angiogenesis. In this study, we investigated the relationship between MMP9 −1562 C/T (rs3918242) polymorphism and the development of T2DM and DR in Turkish population. Material and Method A total of 510 participants, involving 168 T2DM cases with DR, 168 T2DM cases without DR, and 174 controls, were included in the study. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was carried out to identify genotypes. Results The CT, CT+TT genotypes and the T allele of the MMP9 −1562 C/T polymorphism were associated with increased risk of DR (p=0.001). On the other hand, no relationship was found between the development of T2DM and this polymorphism. In addition, CT (p=0.010) and CT+TT (p=0.015) genotype frequencies were found to be higher in proliferative diabetic retinopathy (PDR) cases compared to nonproliferative diabetic retinopathy (NPDR) cases, but after regression analysis, only insulin use (p=0.003) was found to be associated with the development of PDR. Conclusion Our data show that the MMP9 −1562 C/T polymorphism is associated with the development of DR in Turkish T2DM patients, but no significant relationship was found between this polymorphism and the severity of DR and the development of T2DM.

Keywords

• MMP9
• Diabetic retinopathy
• proliferative diabetic retinopathy
• type 2 diabetes mellitus
• polymorphism

MMP9 −1562 C/T POLİMORFİZMİ, TÜRK TİP 2 DİABETES MELLİTUS HASTALARINDA ARTMIŞ DİYABETİK RETİNOPATİ RİSKİ İLE İLİŞKİLİDİR

Abstract

Amaç Tip 2 diabetes mellitus (T2DM) ve diyabetin mikrokomplikasyonlarından olan diyabetik retinopati (DR) gelişimi genetik faktörlerden etkilenmektedir. Matriks metalloproteinazlar (MMPs), ekstraselüler matriks proteinlerinin yeniden şekillendirilmesi ve anjiyogenez gibi pek çok hücresel proseste rol alırlar. Bu çalışmada Türk toplumunda MMP9 −1562 C/T (rs3918242) polimorfizmi ile T2DM ve DR gelişim riski arasındaki ilişkinin araştırılması amaçlanmıştır. Gereç ve Yöntem Mevcut çalışmaya 168 DR’si olan T2DM hastası, 168 DR’si olmayan T2DM hastası ve 174 kontrol olmak üzere toplam 510 birey dahil edilmiştir. Genotipleri belirlemek amacıyla Polimeraz zincir reaksiyonu-Restriksiyon fragment uzunluk polimorfizmi (PCR-RFLP) yöntemi kullanılmıştır. Bulgular T2DM gelişimi ile MMP9 −1562 C/T polimorfizmi arasında bir ilişkiye rastlanmazken, CT ve CT+TT genotipleri ile T (p=0,001) alleli artmış DR riski ile ilişkili bulunmuştur. Ayrıca CT (p=0,010) ve CT+TT (p=0,015) genotip sıklığı proliferatif diyabetik retinopati (PDR) hastalarında proliferatif olmayan diyabetik retinopati (NPDR) hastalarına kıyasla yüksek bulunmuş, fakat regresyon analizi sonrasında sadece insülin kullanımının (p=0,003) PDR gelişimi ile ilişkili olduğu belirlenmiştir. Sonuç Elde ettiğimiz veriler Türk T2DM hastalarında MMP9 −1562 C/T polimorfizminin DR gelişimi ile ilişkili olduğunu, fakat bu polimorfizm ile DR şiddeti ve T2DM gelişimi arasında anlamlı bir ilişki bulunmadığını göstermektedir.

Keywords

• Diabetik retinopati
• MMP9
• Polimorfizm
• Proliferatif diyabetik retinopati
• Tip 2 diabetes mellitus

References

1. 1. Simó-Servat O, Hernández C, Simó R. Diabetic Retinopathy in the Context of Patients with Diabetes. Ophthalmic Res 2019;62(4):211–7.
2. 2. Han J, Lando L, Skowronska-Krawczyk D, Chao DL. Genetics of Diabetic Retinopathy. Curr Diab Rep. 2019;19(9):67.
3. 3. Kowluru RA, Mishra M. Regulation of Matrix Metalloproteinase in the Pathogenesis of Diabetic Retinopathy. Prog Mol Biol Transl Sci 2017;148:67–85.
4. 4. Bhatwadekar AD, Shughoury A, Belamkar A, Ciulla TA. Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World. Genes (Basel) 2021;12(8):1200.
5. 5. Browning DJ, Stewart MW, Lee C. Diabetic macular edema: Evidence-based management. Indian J Ophthalmol 2018;66(12):1736.
6. 6. Simó R, Vujosevic S, Aldington SJ, Silva P, Hernández C, Scanlon P, et al. Screening for diabetic retinopathy: new perspectives and challenges. Rev Lancet Diabetes Endocrinol 2020;8(4):337–84.
7. 7. Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2020;12(8):1322–5.
8. 8. Skol AD, Jung SC, Sokovic AM, Chen S, Fazal S, Sosina O, et al. Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes. Elife 2020;9:1–20.

9. 9. Gajewska B, Śliwińska-Mossoń M. Association of MMP-2 and MMP-9 Polymorphisms with Diabetes and Pathogenesis of Diabetic Complications. Int J Mol Sci 2022;23(18):10571.
10. 10. Mohammad G, Kowluru RA. Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9. J Cell Physiol 2012;227(3):1052–61.
11. 11. Zhang Z, Wu X, Cai T, Gao W, Zhou X, Zhao J, et al. Matrix Metalloproteinase 9 Gene Promoter (rs 3918242) Mutation Reduces the Risk of Diabetic Microvascular Complications. Int J Environ Res Public Health 2015;12(7):8023–33.
12. 12. Singh K, Goyal P, Singh M, Deshmukh S, Upadhyay D, Kant S, et al. Association of functional SNP-1562C>T in MMP9 promoter with proliferative diabetic retinopathy in north Indian type 2 diabetes mellitus patients. J Diabetes Complications 2017;31(12):1648–51.
13. 13. Singh K, Agrawal NK, Gupta SK, Singh K. A Functional Single Nucleotide Polymorphism -1562C>T in the Matrix Metalloproteinase-9 Promoter Is Associated With Type 2 Diabetes and Diabetic Foot Ulcers. 2013;12(3):199-204.
14. 14. Committee ADAPP. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care 2022;45(S1):S17–38.
15. 15. Saravani S, Yari D, Saravani R, Ahmadabadi CA. Association of COL4A3 (rs55703767), MMP-9 (rs17576) and TIMP-1 (rs6609533) gene polymorphisms with susceptibility to type 2 diabetes. Biomed Reports 2017;6(3):329–34.
16. 16. Feng S, Ye G, Bai S, Wei H, Liao X, Li L. Matrix Metalloproteinase-9 −1562C/T Gene Polymorphism Is Associated with Diabetic Nephropathy. Biomed Res Int 2016;2016:1627143.
17. 17. Shalaby K, Bahriz R , Mahsoub MME-A N, Said GE. Matrix metalloproteinase-9 gene polymorphism (-1562 C/T) and its correlation with diabetic nephropathy. Egypt J Intern Med. 2021;33:7.
18. 18. Singh K, Agrawal NK, Gupta SK, Mohan G, Chaturvedi S, Singh K. Differential Expression of Matrix Metalloproteinase-9 Gene in Wounds of Type 2 Diabetes Mellitus Cases With Susceptible -1562C>T Genotypes and Wound Severity. Int J Low Extrem Wounds 2014;13(2):94–102.
19. 19. Beránek M, Kolar P, Tschoplova S, Kankova K, Vasku A. Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy. Mol Vis 2008;14:1114–21.